Pliant Therapeutics Stock Target Price and Analyst Consensus

PLRX Stock  USD 1.54  0.02  1.32%   
The current analyst and expert consensus on Pliant Therapeutics is Strong Buy, with 8 strong buy opinions. The current projected Pliant Therapeutics target price consensus is 40.18 with 13 analyst opinions. Check out Macroaxis Advice on Pliant Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.
The most common way Pliant Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Pliant Therapeutics executives and customers to further validate their buy or sell advice. Pliant Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Pliant Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 12.9258.
Lowest Forecast
36.57
Highest Forecast
44.6
Target Price
40.18
Gross Profit is likely to drop to about 1.4 M in 2025. Pretax Profit Margin is likely to rise to -111.56 in 2025. At this time, Pliant Therapeutics' Property Plant And Equipment Gross is fairly stable compared to the past year.
  
It's important to approach Pliant Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Pliant Therapeutics price targets

Pliant Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Pliant Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Pliant Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Pliant Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Pliant Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Pliant Therapeutics is a key component of Pliant Therapeutics valuation and have some predictive power on the future returns of a Pliant Therapeutics.
Hype
Prediction
LowEstimatedHigh
0.101.9714.90
Details
Intrinsic
Valuation
LowRealHigh
0.5611.1924.12
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.9-0.63-0.46
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Macroaxis Index Idea
Macroaxis Index
Sold over 90 shares
Basic Utilities Idea
Basic Utilities
Invested over 90 shares

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.